Skip to main content
Erschienen in: Journal of Gastroenterology 3/2010

01.03.2010 | Original Article—Alimentary Tract

Pancreatic acinar metaplasia in the distal oesophagus and the gastric cardia: prevalence, predictors and relation to GORD

verfasst von: Johan Johansson, Hans-Olof Håkansson, Lennart Mellblom, Antti Kempas, Gerhard Kjellén, Lars Brudin, Fredrik Granath, Karl-Erik Johansson, Olof Nyrén

Erschienen in: Journal of Gastroenterology | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The nature of pancreatic acinar metaplasia (PAM) in the gastro-oesophageal junction (GOJ) remains obscure. We aimed to estimate its prevalence and investigate into its risk factors in a population-based series of first-time endoscopy patients.

Methods

We investigated consecutive patients, endoscoped for the first time, representing defined catchment area populations. Biopsies were taken immediately below the GOJ and from the distal oesophagus. Endoscopy room-based cross-sectional clinical data were supplemented with exposure data from 160 population controls. Associations, expressed as odds ratios (OR), were modelled with multivariable logistic regression. A subsample of 26 patients underwent oesophageal pH monitoring.

Results

Among 644 patients (mean age 53 years, 43% men), PAM was found in 121 patients (19%), exclusively above the GOJ in 40 (6%), below GOJ in 67 (10%), and both above and below GOJ in 14 (2%). PAM exclusively above the GOJ and PAM exclusively below the GOJ were both borderline associated with age (2% increase in prevalence per year). PAM exclusively above the GOJ was significantly associated with female gender (OR 2.8, 95% CI 1.3–6.3) and presence of Helicobacter pylori immediately below the GOJ (OR 2.6, 95% CI 1.3–5.4). Out of 21 patients with Barrett’s oesophagus (BO), 8 (38%) had PAM above the GOJ. The mean value for percentage time with oesophageal pH < 4.0 was 7.3% (95% CI 4.3–10.2%) among patients who had PAM above the GOJ (reference value 3.4%).

Conclusions

Pancreatic acinar metaplasia might be an age-dependent lesion, associated with H. pylori, female gender and gastro-oesophageal reflux if located above the GOJ.
Literatur
1.
Zurück zum Zitat Doglioni C, Laurino L, Dei Tos AP, De Boni M, Franzin G, Braidotti P, et al. Pancreatic (acinar) metaplasia of the gastric mucosa. Histology, ultrastructure, immunocytochemistry, and clinicopathologic correlations of 101 cases. Am J Surg Pathol. 1993;17:1134–43.CrossRefPubMed Doglioni C, Laurino L, Dei Tos AP, De Boni M, Franzin G, Braidotti P, et al. Pancreatic (acinar) metaplasia of the gastric mucosa. Histology, ultrastructure, immunocytochemistry, and clinicopathologic correlations of 101 cases. Am J Surg Pathol. 1993;17:1134–43.CrossRefPubMed
2.
Zurück zum Zitat Wang HH, Zeroogian JM, Spechler SJ, Goyal RK, Antonioli DA. Prevalence and significance of pancreatic acinar metaplasia at the gastroesophageal junction. Am J Surg Pathol. 1996;20:1507–10.CrossRefPubMed Wang HH, Zeroogian JM, Spechler SJ, Goyal RK, Antonioli DA. Prevalence and significance of pancreatic acinar metaplasia at the gastroesophageal junction. Am J Surg Pathol. 1996;20:1507–10.CrossRefPubMed
3.
Zurück zum Zitat Krishnamurthy S, Dayal Y. Pancreatic metaplasia in Barrett’s esophagus. An immunohistochemical study. Am J Surg Pathol. 1995;19:1172–80.PubMedCrossRef Krishnamurthy S, Dayal Y. Pancreatic metaplasia in Barrett’s esophagus. An immunohistochemical study. Am J Surg Pathol. 1995;19:1172–80.PubMedCrossRef
4.
Zurück zum Zitat Johansson J, Hakansson HO, Mellblom L, Kempas A, Johansson KE, Granath F, et al. Prevalence of precancerous and other metaplasia in the distal oesophagus and gastro-oesophageal junction. Scand J Gastroenterol. 2005;40:893–902.CrossRefPubMed Johansson J, Hakansson HO, Mellblom L, Kempas A, Johansson KE, Granath F, et al. Prevalence of precancerous and other metaplasia in the distal oesophagus and gastro-oesophageal junction. Scand J Gastroenterol. 2005;40:893–902.CrossRefPubMed
5.
Zurück zum Zitat Hakansson HO, Mellblom L, Johansson J, Bjartell A, Borgstrom A. Synthesis and localization of pancreatic secretory proteins in pancreatic acinar-like metaplasia in the distal part of the oesophagus. Pancreatic acinar metaplasia: another source of pancreatic enzymes!. Scand J Gastroenterol. 2003;38:10–3.PubMed Hakansson HO, Mellblom L, Johansson J, Bjartell A, Borgstrom A. Synthesis and localization of pancreatic secretory proteins in pancreatic acinar-like metaplasia in the distal part of the oesophagus. Pancreatic acinar metaplasia: another source of pancreatic enzymes!. Scand J Gastroenterol. 2003;38:10–3.PubMed
6.
Zurück zum Zitat Jhala NC, Montemor M, Jhala D, Lu L, Talley L, Haber MM, et al. Pancreatic acinar cell metaplasia in autoimmune gastritis. Arch Pathol Lab Med. 2003;127:854–7.PubMed Jhala NC, Montemor M, Jhala D, Lu L, Talley L, Haber MM, et al. Pancreatic acinar cell metaplasia in autoimmune gastritis. Arch Pathol Lab Med. 2003;127:854–7.PubMed
7.
Zurück zum Zitat el-Zimaity HM, Verghese VJ, Ramchatesingh J, Graham DY. The gastric cardia in gastro-oesophageal disease. J Clin Pathol. 2000;53:619–25.CrossRefPubMed el-Zimaity HM, Verghese VJ, Ramchatesingh J, Graham DY. The gastric cardia in gastro-oesophageal disease. J Clin Pathol. 2000;53:619–25.CrossRefPubMed
8.
Zurück zum Zitat Polkowski W, van Lanschot JJ, ten Kate FJ, Rolf TM, Polak M, Tytgat GN, et al. Intestinal and pancreatic metaplasia at the esophagogastric junction in patients without Barrett’s esophagus. Am J Gastroenterol. 2000;95:617–25.CrossRefPubMed Polkowski W, van Lanschot JJ, ten Kate FJ, Rolf TM, Polak M, Tytgat GN, et al. Intestinal and pancreatic metaplasia at the esophagogastric junction in patients without Barrett’s esophagus. Am J Gastroenterol. 2000;95:617–25.CrossRefPubMed
9.
Zurück zum Zitat Johansson J, Hakansson HO, Mellblom L, Kempas A, Johansson KE, Granath F, et al. Risk factors for Barrett’s oesophagus: a population-based approach. Scand J Gastroenterol. 2007;42:148–56.CrossRefPubMed Johansson J, Hakansson HO, Mellblom L, Kempas A, Johansson KE, Granath F, et al. Risk factors for Barrett’s oesophagus: a population-based approach. Scand J Gastroenterol. 2007;42:148–56.CrossRefPubMed
10.
Zurück zum Zitat Miller LS. Endoscopy of the esophagus. In: Castell DO, editor. The esophagus. Boston: Little, Brown & Co; 1992. p. 89–142. Miller LS. Endoscopy of the esophagus. In: Castell DO, editor. The esophagus. Boston: Little, Brown & Co; 1992. p. 89–142.
11.
Zurück zum Zitat Armstrong D, Bennett JR, Blum AL, Dent J, De Dombal FT, Galmiche JP, et al. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterol. 1996;111:85–92.CrossRef Armstrong D, Bennett JR, Blum AL, Dent J, De Dombal FT, Galmiche JP, et al. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterol. 1996;111:85–92.CrossRef
13.
Zurück zum Zitat Lagergren J, Bergström R, Lindgren A, Nyrén O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340:825–31.CrossRefPubMed Lagergren J, Bergström R, Lindgren A, Nyrén O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340:825–31.CrossRefPubMed
14.
Zurück zum Zitat Kjellen G, Brudin L, Hakansson HO. Is scintigraphy of value in the diagnosis of gastrooesophageal reflux disease? Scand J Gastroenterol. 1991;26:425–30.CrossRefPubMed Kjellen G, Brudin L, Hakansson HO. Is scintigraphy of value in the diagnosis of gastrooesophageal reflux disease? Scand J Gastroenterol. 1991;26:425–30.CrossRefPubMed
15.
Zurück zum Zitat Johnsson F, Joelsson B, Isberg PE. Ambulatory 24 hour intraesophageal pH-monitoring in the diagnosis of gastroesophageal reflux disease. Gut. 1987;28:1145–50.CrossRefPubMed Johnsson F, Joelsson B, Isberg PE. Ambulatory 24 hour intraesophageal pH-monitoring in the diagnosis of gastroesophageal reflux disease. Gut. 1987;28:1145–50.CrossRefPubMed
16.
Zurück zum Zitat Bland M. An introduction to medical statistics. 3rd ed. Oxford: Oxford University Press; 2000. Bland M. An introduction to medical statistics. 3rd ed. Oxford: Oxford University Press; 2000.
17.
Zurück zum Zitat Glickman JN, Fox V, Antonioli DA, Wang HH, Odze RD. Morphology of the cardia and significance of carditis in pediatric patients. Am J Surg Pathol. 2002;26:1032–9.CrossRefPubMed Glickman JN, Fox V, Antonioli DA, Wang HH, Odze RD. Morphology of the cardia and significance of carditis in pediatric patients. Am J Surg Pathol. 2002;26:1032–9.CrossRefPubMed
18.
Zurück zum Zitat Malfertheiner P, Sipponen P, Naumann M, Moayyedi P, Megraud F, Xiao SD, et al. Helicobacter pylori eradication has the potential to prevent gastric cancer: a state-of-the-art critique. Am J Gastroenterol. 2005;100:2100–15.CrossRefPubMed Malfertheiner P, Sipponen P, Naumann M, Moayyedi P, Megraud F, Xiao SD, et al. Helicobacter pylori eradication has the potential to prevent gastric cancer: a state-of-the-art critique. Am J Gastroenterol. 2005;100:2100–15.CrossRefPubMed
19.
Zurück zum Zitat Hagiwara T, Mukaisho K, Ling ZQ, Sugihara H, Hattori T. Development of pancreatic acinar cell metaplasia after successful administration of omeprazole for 6 months in rats. Dig Dis Sci. 2007;52:1219–24.CrossRefPubMed Hagiwara T, Mukaisho K, Ling ZQ, Sugihara H, Hattori T. Development of pancreatic acinar cell metaplasia after successful administration of omeprazole for 6 months in rats. Dig Dis Sci. 2007;52:1219–24.CrossRefPubMed
20.
Zurück zum Zitat Spechler SJ. Intestinal metaplasia at the gastroesophageal junction. Gastroenterology. 2004;126:567–75.CrossRefPubMed Spechler SJ. Intestinal metaplasia at the gastroesophageal junction. Gastroenterology. 2004;126:567–75.CrossRefPubMed
Metadaten
Titel
Pancreatic acinar metaplasia in the distal oesophagus and the gastric cardia: prevalence, predictors and relation to GORD
verfasst von
Johan Johansson
Hans-Olof Håkansson
Lennart Mellblom
Antti Kempas
Gerhard Kjellén
Lars Brudin
Fredrik Granath
Karl-Erik Johansson
Olof Nyrén
Publikationsdatum
01.03.2010
Verlag
Springer Japan
Erschienen in
Journal of Gastroenterology / Ausgabe 3/2010
Print ISSN: 0944-1174
Elektronische ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-009-0161-4

Weitere Artikel der Ausgabe 3/2010

Journal of Gastroenterology 3/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.